Eric Shih Katsuyama

🎓 | MD 🇧🇷 | FMABC 2021 🔬 | Teaching Assistant II PPCR 2024 @harvardchansph 📊 | Director of Specialties and Mentorat @metaacademy_ofc

[Dr Bezalel MBBS @DrBezMD]

Another milestone to celebrate!

I’m delighted to share that one of my co-authored research articles has been published in Neurology @GreenJournal - The most widely read and highly cited peer-reviewed neurology journal.

A meta analysis of 126 RCTs comprising 24,614 participants.

Grateful to all my co-authors and mentors who made this possible.
Thankful to @metaacademy_ofc for providing the training that helped shape my research skills.

Onward and upward!

🔗 https://t.co/uebmuoSaUu

@erickatsuyama97 @metaacademy_ofc
@Wolters_Kluwer @VanioAntunes @AANmember @wkhealth

#Neurology #Research #MedicalResearch #AcademicMedicine #PubMed #Science

[Christian Ken Fukunaga @christiankfuku]

🚨New publication in the European Journal of Preventive Cardiology🚨

Does aspirin benefit patients with elevated Lipoprotein(a) [Lp(a)] in primary prevention?

In our meta-analysis of 6 studies (6,628 patients), aspirin was:

▫️ NOT associated with significant MACE reduction
▫️ Associated with numerically higher bleeding risk
▫️ Inconsistent even among high-risk LPA genotype carriers

🔗 https://t.co/W3Bf7UXDRX

@rodolfolopesmd @CarlosVergaraMD @JUATASO @erickatsuyama97 @DrEugeneYang @DrMichaelShapir

@ESC_Journals @EJPCEiC @AboyansV

#CardioTwitter #CardioX #ESC #EJPC #PreventiveCardiology #MedX

[Stroke AHA/ASA @StrokeAHA_ASA]

#STROKE: This topical review by Andrade et al. discusses how the global shift to digital health can transform stroke care in LMICs. @erickatsuyama97 @GiseleSampaioS #AHAJournals https://t.co/IoicNkaWGd

[Meta Analysis Academy @metaacademy_ofc]

#StatsMonth kicked off today with a high-yield live session on Forest Plots in RStudio, led by Dr. @erickatsuyama97 in collaboration with @henriqueafneves

Real data, step-by-step guidance, and engaging questions from participants. Applied stats made practical. Just how it should be.

Next up:
📌 Single-arm MA
📌 Diagnostic MA
📌 Network MA

Every Sunday in June.

Recordings for the MetaHub community + current Meta-Analysis Academy students.

#MedTwitter #MedicalResearch

[Eric Shih Katsuyama @erickatsuyama97]

@metaacademy_ofc The research groups at the Meta-Analysis Academy are a great opportunity to connect with students who share similar interests! Through them, I found colleagues with whom I still conduct research today!

[Meta Analysis Academy @metaacademy_ofc]

🔥 INSIDE THE META-ACADEMY: Experts Program and Research Groups

Imagine this: You finally have the chance to do research, but… where do you start?

You have ideas but no guidance. You want to collaborate, but you don’t know the right people. You need mentorship, but nobody seems available.

This is where the Experts Program and Research Groups inside Meta-Academy change everything.

[Eric Shih Katsuyama @erickatsuyama97]

I am honored by the recognition in this incredible work. Many thanks to the @metaacademy_ofc

[Pasquale Paolisso @P_Paolisso]

👥Systematic meta-analysis of 10 RCTs (>22,000 pts - 51.2% w/T2DM) to determine the impact of SGLT2i in pts w/ recent or previous MI.
🗓️Mean age 62 yrs; median FU was 21 months.

Main findings:
💥HF hospitalization rates were ⬇️in pts on SGLT2i compared with placebo (RR 0.77; 95% CI 0.69, 0.85; p<0.001).

💥These benefits of SGLT2i were consistent regardless of the timing of the last MI.

💥No statistically significant difference in all-cause mortality was observed between the groups (RR 0.88; 95% CI 0.78, 1.00; p=0.058).

Read more on #CardiovascularDiabetology @BioMedCentral 👇
https://t.co/dNKZ0xogjw

[Pasquale Paolisso @P_Paolisso]

👥Systematic meta-analysis of 10 RCTs (>22,000 pts - 51.2% w/T2DM) to determine the impact of SGLT2i in pts w/ recent or previous MI.
🗓️Mean age 62 yrs; median FU was 21 months.

Main findings:
💥HF hospitalization rates were ⬇️in pts on SGLT2i compared with placebo (RR 0.77; 95% CI 0.69, 0.85; p<0.001).

💥These benefits of SGLT2i were consistent regardless of the timing of the last MI.

💥No statistically significant difference in all-cause mortality was observed between the groups (RR 0.88; 95% CI 0.78, 1.00; p=0.058).

Read more on #CardiovascularDiabetology @BioMedCentral 👇
https://t.co/dNKZ0xogjw

[Pedro Gabriel Scardini @pedroscardini]

🚨 Exciting news! Our meta-analysis on SGLT2i in MI patients has been accepted for publication in Cardiovascular Diabetology!

🔎 Key findings:
✅ SGLT2i reduced MACE events &amp; heart failure hospitalizations
✅ Supports broader use post-MI

Grateful to my co-authors &amp; mentors!🙌

[Eric Shih Katsuyama @erickatsuyama97]

2024 was an extraordinary year as a proud #MetaMaster! 🚀 I had the privilege of being a co-author of the study "Cardioneuroablation in patients with vasovagal syncope: An updated systematic review and meta-analysis" by Prata et al. 🌟

#MetaAnalysisAcademy #MetaMasters

[Meta Analysis Academy @metaacademy_ofc]

The countdown to the New Year has begun! 🚀

Show us a paper you presented or published this year—we love to see our #MetaMasters going to the moon! 🌕

[Meta Analysis Academy @metaacademy_ofc]

As we approach the end of the year, you've likely  attended at least one conference this year or you're planning to attend one next year.

But have you ever had any concerns about how to properly network during a conference ?

Here well give you some tips 👇

[HeartRhythm @hrs_journal]

Cardioneuroablation in Patients with Vasovagal Syncope: An updated systematic review and meta-analysis
@erickatsuyama97, @christiankfuku, @pedroscardini, @VanioAntunes, @AnaCCoan
https://t.co/MvCJqzDRYy